Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Soudet

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Respiratory Medicine and Research|December 23, 2023
Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?Bastien Petit, Simon Soudet, Géraldine Poenou, et al.
Thrombosis and Haemostasis|February 10, 2022
Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)Benjamin Planquette, Lina Khider, Alice Le Berre, et al.
Research and Practice in Thrombosis and Haemostasis|February 9, 2026
Prevalence of abnormal uterine bleeding and quality of life after venous thromboembolism by oral anticoagulant use: the GENB-OAC StudyGabrielle Sarlon-Bartoli, Barbara Leclercq, Nathalie Trillot, et al.
Eclinicalmedicine|June 23, 2023
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trialStéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Respiratory Medicine and Research|December 23, 2023
Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?Bastien Petit, Simon Soudet, Géraldine Poenou, et al.
Thrombosis and Haemostasis|February 10, 2022
Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)Benjamin Planquette, Lina Khider, Alice Le Berre, et al.
Research and Practice in Thrombosis and Haemostasis|February 9, 2026
Prevalence of abnormal uterine bleeding and quality of life after venous thromboembolism by oral anticoagulant use: the GENB-OAC StudyGabrielle Sarlon-Bartoli, Barbara Leclercq, Nathalie Trillot, et al.
Eclinicalmedicine|June 23, 2023
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trialStéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
Pageof 3